Information  X 
Enter a valid email address

Omega Diagnostics Gp (ODX)

  Print   

Monday 15 March, 2021

Omega Diagnostics Gp

Statement re. Government press release

RNS Number : 3227S
Omega Diagnostics Group PLC
15 March 2021
 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Statement re. Government press release

 

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the press release issued this afternoon by the UK Government announcing its partnership with British rapid test manufacturers.

 

Further to the RNS announcement released by Omega this morning at 7am, the Company is named as one of two British companies to have secured contracts with the Government to supply rapid lateral flow tests.

 

Quote in the press release Colin King, CEO of Omega Diagnostics Group plc, said:

"We are delighted to deploy our state-of-the-art lateral flow test production facilities in support of the UK government's COVID-19 testing programme. The collaboration with other UK-based  IVD companies and DHSC has facilitated the rapid development and manufacturing capability within the UK. We particularly welcome the government's assistance to secure the specialist machinery needed to dramatically increase the scale of our manufacturing capacity which has allowed us to ensure a ready supply of high quality, reliable British made rapid lateral flow tests.

 

"Rapid lateral flow tests are an essential tool for identifying COVID-19 cases where people have no visible symptoms but could still be infectious and continue to spread the virus. We are very proud to be playing our part in the nation's effort to control the spread of coronavirus by using our production facilities in Scotland."

 

The full text of the press release can be seen here:

https://www.gov.uk/government/news/uk-government-announces-partnership-with-british-rapid-test-manufacturers

 

The following press release was also released in Scotland:

https://www.gov.uk/government/news/uk-government-to-partner-with-clackmannanshire-test-manufacturer

 

 

 

Contacts: 

 

Omega Diagnostics Group PLC   

www.omegadiagnostics.com

Colin King, Chief Executive 

via Walbrook PR

Kieron Harbinson, Group Finance Director




finnCap Ltd  

Tel: 020 7220 0500

Geoff Nash/Edward Whiley (Corporate Finance)


Alice Lane (ECM)




Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGPUQPWUPGGMA

a d v e r t i s e m e n t